Skip to main content

Advertisement

Table 2 Outcomes of IVF/ICSI cycles in women of advanced reproductive age (≥ 40 years old)

From: The predictability of serum anti-Müllerian level in IVF/ICSI outcomes for patients of advanced reproductive age

   Serum AMH tertiles (ng/mL)
  Total subjects Low (≤ 0.48) Middle (0.49~1.22) High (≥ 1.23)
Total cycle 116 21 38 57
Cancelled cycle (%) 17 (14.7) 10 (47.6)§ 6 (15.7)* 1 (1.7)
Mean age 41.5 ± 1.4 42.8 ± 2.3 41.1 ± 1.3 41.3 ± 1.4
Peak E2 level (pg/mL) 1542.1 ± 1146.5 802.6 ± 748.9 1050 ± 699 2095.8 ± 1156.2
Number of oocytes retrieved 6.1 ± 4.6 2.4 ± 2.9 4.7 ± 2.5 8.1 ± 5.1
Number of mature oocytes 4.7 ± 3.7 1.5 ± 1.73 3.9 ± 2.5 6.3 ± 3.9
Embryos obtained 3.8 ± 2.9 1.8 ± 2.4 3.1 ± 2.2 4.8 ± 3.1
Embryos transferred 2.8 ± 1.2 1.6 ± 1.3 2.6 ± 1.0 3.2 ± 1.0
Clinical pregnancy per cycle (%) 26 (22.4) 0 (0)§ 9 (23.7) 17 (29.8)
Abortion per cycle (%) 7 (26.9) 0 (0) 0 (0) 7 (41.2)
Viable pregnancy per cycle (%) [FHB (+) & > 7 wks.] 19 (16.4) 0 (0) 9 (23.7) 10 (17.5)
  1. § p < 0.05 compared with the middle tertile and the high tertile
  2. *p < 0.05 compared with the high tertile
  3. p < 0.05 compared with the middle tertile